POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP SOLUTION

Страна: Канада

Език: английски

Източник: Health Canada

Активна съставка:

SODIUM CHLORIDE; POTASSIUM CHLORIDE

Предлага се от:

BAXTER CORPORATION

АТС код:

B05BB01

INN (Международно Name):

ELECTROLYTES

дозиране:

450MG; 150MG

Лекарствена форма:

SOLUTION

Композиция:

SODIUM CHLORIDE 450MG; POTASSIUM CHLORIDE 150MG

Начин на приложение:

INTRAVENOUS

Броя в опаковка:

1000ML

Вид предписание :

Ethical

Терапевтична област:

REPLACEMENT PREPARATIONS

Каталог на резюме:

Active ingredient group (AIG) number: 0213340004; AHFS:

Статус Оторизация:

MARKETED

Дата Оторизация:

2008-03-31

Данни за продукта

Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 1 of 14_
PRESCRIBING INFORMATION
POTASSIUM CHLORIDE IN 0.45% SODIUM CHLORIDE INJECTION, USP
IN PLASTIC CONTAINER
VIAFLEX
Container
20 mmol/L Potassium Chloride in 0.45% Sodium Chloride Injection
SOLUTION FOR INFUSION
Solutions Affecting the Electrolyte Balance
BAXTER CORPORATION
Mississauga, ON L5N 0C2
Date of Revision:
December 10, 2018
Control No. 221539
Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 2 of 14_
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
....................................................................................3
INDICATIONS AND CLINICAL USE
..........................................................................................3
CONTRAINDICATIONS
...............................................................................................................3
WARNINGS AND PRECAUTIONS
..............................................................................................3
SPECIAL POPULATIONS
.............................................................................................................7
ADVERSE REACTIONS
................................................................................................................8
DRUG INTERACTIONS
................................................................................................................8
DOSAGE AND ADMINISTRATION
............................................................................................9
INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL
............................................10
DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
..................................11
OVERDOSE
..................................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
........................................................................13
STORAGE AND STABILITY
..................